Business Wire

Verimatrix Secures the Connected Content Workflow at NAB 2019


NAB Show 2019 (Booth #SU3110) – Verimatrix, an Inside Secure (Euronext Paris – INSD) company, will be highlighting its spectrum of cloud-based solutions that combine world-class security techniques with 360-degree analytics capabilities, providing trusted insights from the head-end to the device at the NAB Show 2019.

"The long-term success of connected devices and services in any industry will largely depend on the security measures in place to eliminate evolving threats and provide a transparent user experience. By leveraging our position in the network, we have taken this further by monitoring the data that flows across all devices and network types within video service delivery,” said Steve Oetegenn, COO of Verimatrix. “At NAB, we are demonstrating how this combination enables us to offer highly efficient and secure distribution platforms that provide new business insights for customers looking to maintain a competitive edge.”

The cloud is at the core of the company’s demonstrations leveraging the operational efficiencies and inherent flexibility of cloud-based workflows. Illustrating the product synergies of the newly combined company, Verimatrix will be highlighting an expanded and strengthened MultiRights™ OTT multi-DRM solution, offered as a cloud service or an on-premise deployment. Combining the Verimatrix multi-DRM solution, featuring harmonized rights management, with Inside Secure’s proven Content Protection Client and Code Protection demonstrates the benefits of the complete, end-to-end, and highly secure solution for the protection of premium pay-TV content on any device.

For content providers, connected content distribution services will also be on display. nTitleMe™ is a cloud-based SaaS that streamlines content provider-operator relationships with a single integration for subscriber authentication, allowing subscribers to log-in once for a frictionless TV Everywhere experience. RightsConnex™ is an “encrypt once, deliver everywhere” distribution solution that improves security, visibility and control over the content distribution and management operations within a cloud-based video workflow.

Verimatrix will also be highlighting watermarking-as-a-service offering by its server-side StreamMark™ and StreamMark™ Origin solutions for video-on-demand (VOD) content. StreamMark Origin, a cloud service for business-to-business (B2B) anti-piracy protection, will demonstrate the benefits of embedding an origin watermark in B2B content in order to identify the affiliate or operator that receives the stream and any consequent leaks along that delivery chain. This type of upstream watermarking enables new business models for premium content, such as early release windows, with a higher level of confidence to deter/reduce piracy.

The Verspective® Analytics solution suite will be on display to illustrate how Verspective RT and Verspective Intelligence – both offered as a cloud SaaS – can help reduce churn, increase average revenue per user (ARPU) and reduce total cost of ownership. Verspective aggregates network and device data into a secure, cloud-based data lake, while granting secure and role-based access to each department such as operations, marketing, content, product and advertising sales. Verspective is offered as a standalone SaaS that can be easily integrated with existing systems for operators and content providers, or as a complement to the Verimatrix Video Content Authority System (VCAS™), an end-to-end content and revenue security architecture for all kinds of networks and device types.

Key events:

  • The Changing Face of Pay-TV PiracyApr. 10 - 10:40am, N258
    CTO Petr Peterka will put into perspective how much pirated media content has changed since the advent of IP video and OTT distribution. The same infrastructure and tools that have revolutionized video distribution and enabled an explosion of content have also been exploited by pirates for illicit redistribution. He will explain the new methods and tools to best address piracy.
  • 4K 4Charity Fun RunApr. 9 - 7:30am Sunset Park, Las Vegas
    Verimatrix is a proud sponsor of the 4K 4Charity Fun Run. Girls Who Code, this year’s beneficiary, is a national non-profit organization working to close the gender gap in technology and change the image of what a programmer looks like and does.
  • PRODU Technologia Awards Apr. 9, 12:00pm, NAB Studio between North and Central Halls
    The Verimatrix deployment with Izzi Telecom of the Verimatrix Secure Cloud for the 2018 FIFA World Cup has been shortlisted in the Technology Project category.
  • IABM BaM Awards® 2019Apr. 9 – 6:00pm, The Westgate
    nTitleMe has been shortlisted in the Consume category for IABM BaM Awards as one of 40 companies at the NAB Show.
  • NAB Product of the Year Awards – Apr. 10 – 5:30pm, Ballroom , The Westgate
    Verimatrix has been named an official nominee in the first-ever NAB Show Product of the Year Awards for its nTitleMe solution.

For additional information about Verimatrix’s presence during the NAB Show 2019 or to book an appointment, please visit Follow the conversation at #NABShow.

About Verimatrix

Verimatrix specializes in enhancing and securing revenue for connected devices and IP-based services around the world. Recognizing the need to improve digital exchange between content providers, video service operators, and subscribers, Verimatrix is focused on enhancing the connected content distribution workflow by leveraging its award-winning VCAS™ security and Verspective® Analytics solutions, and unmatched partner ecosystem, to reduce the costs and complexities associated with legacy distribution workflows. To learn more, visit, our Pay TV Views blog and follow us @verimatrixincFacebook and LinkedIn to join the conversation.

About Inside Secure

Inside Secure (Euronext Paris – INSD) is at the heart of security solutions for mobile and connected devices, providing software, silicon IP, tools, services, and know-how needed to protect customers’ transactions, ID, content, applications, and communications. With its deep security expertise and experience, the company delivers products having advanced and differentiated technical capabilities that span the entire range of security requirement levels to serve the demanding markets of network security, IoT and System-on-Chip security, video content and entertainment, mobile payment and banking, enterprise and telecom. Inside Secure’s technology protects solutions for a broad range of customers, including service providers, operators, content distributors, security system integrators, device makers and semiconductor manufacturers. For more information, visit

Contact information

Kelly Foster, Verimatrix
+1 619-224-1261

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation18.4.2019 10:00:00 CESTPressemelding

Phyton Biotech, a German/North American Plant Cell Fermentation (PCF®) technology company, and AqVida, a German oncology Finished Dosage Formulation (FDF) manufacturer, are pleased to announce today that they have received European approval from the EDQM (European Directorate of Quality Medicines) for AqVida’s paclitaxel injectable FDF. This press release features multimedia. View the full release here: Phyton Biotech is the world’s leading manufacturer of paclitaxel active pharmaceutical ingredient (API), utilizing its prorprietary PCF® technology process. Under the strategic partnership with AqVida, Phyton Biotech will be the exclusive supplier of paclitaxel API for AqVida’s Taxol generic formulation, which is produced in AqVida’s new state-of-the-art injectable manufacturing facility located in Dassow, Germany. AqVida’s ultramodern robotic manufacturing line, designed for filling cytotoxic injectables, will be utilized to pro

Racketeering Lawsuit Filed by Boies Schiller Flexner LLP Alleges Czech Oligarch Defrauds US Hedge Fund and Former Partner Out of Over $1 Billion18.4.2019 07:41:00 CESTPressemelding

New York hedge fund, Kingstown Capital Management L.P, and other plaintiffs filed a lawsuit on 10 April 2019 in the Southern District of New York against Radovan Vitek, a Czech real estate mogul with business interests throughout Europe, whose fortune Forbes magazine estimates at $3.5 billion. Represented by litigation powerhouse Boies Schiller Flexner LLP, the hedge fund Kingstown Capital Management L.P and Czech investment firm Investhold Ltd allege that Vitek ran an elaborate criminal enterprise that defrauded the plaintiffs out of more than US $1 billion. According to the complaint, Berlin’s largest commercial real estate landlord, Vitek engaged in racketeering activity including wire fraud, mail fraud, money laundering, and other crimes and amassed his wealth at the expense of the plaintiffs, according to the complaint. His commercial interests span multiple jurisdictions including the Czech Republic, Switzerland, Luxembourg, Germany, Croatia and UK. The complaint alleges that Vit

MHI Thermal Systems Develops Demonstration Unit of the World’s First Small-Capacity Residential Air-Conditioner Adopting the Low-GWP R454C Refrigerant18.4.2019 07:21:00 CESTPressemelding

Premiering for the first time in the world, Mitsubishi Heavy Industries Thermal Systems, Ltd., a Group company of Mitsubishi Heavy Industries, Ltd. (MHI) (TOKYO: 7011), is adopting R454C, a refrigerant with an extremely low global warming potential (GWP), in a 1-horsepower (HP) class residential air-conditioner. The conventional shortcomings of the R454C,for example; inferior heat exchanger performance attributable to it being a mixed refrigerant have been overcome through the use of proprietary technology that optimize the heat exchanger’s flow volume and other measures. The company has already developed a demonstration unit of the residential air-conditioner featuring R454C and preparations are underway towards mass production with an eye on an initial launch into the European market, where environmental regulations are particularly stringent. This press release features multimedia. View the full release here: Residential type

Hologic Receives European CE Mark for ThinPrep® Genesis Processor, an Automated Cytology Slide and Molecular Sample System18.4.2019 07:00:00 CESTPressemelding

Hologic, Inc. (Nasdaq: HOLX) announced today that the ThinPrep® Genesis processor for cytology slide and molecular test preparation has received a CE IVD mark in Europe. The system features increased automation capabilities, together with ergonomic and chain of custody benefits, compared to older instruments. Most importantly, the instrument will prepare slides for cytology as well as aliquot samples for molecular testing, reducing manual sample handling. This press release features multimedia. View the full release here: ThinPrep Genesis processor (Photo: Business Wire) The Genesis processor is the latest extension of the ThinPrep portfolio, which revolutionized and increased the accuracy of cervical cancer screening with the first liquid-based Pap test in 1996. Hologic launched an updated ThinPrep® 2000 processor in 2017 and received FDA approval in 2018 for the ThinPrep® Integrated Imager, which guides cytotechnologists to ar

Ipsen Completes Acquisition of Clementia Pharmaceuticals18.4.2019 05:00:00 CESTPressemelding

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) and Clementia Pharmaceuticals (NASDAQ: CMTA) today announced the closing of Ipsen’s acquisition of Clementia following approval of the arrangement by Clementia shareholders and the Quebec Superior Court. Pursuant to the arrangement, Clementia shareholders will receive US$25.00 per share in cash upfront and one contingent value right (CVR) per share entitling them to receive US$6.00 per CVR upon the U.S. Food and Drug Administration's (FDA) acceptance of the regulatory filing for palovarotene for the treatment of multiple osteochondromas (MO). Clementia’s key late-stage clinical asset palovarotene is an investigational retinoic acid receptor gamma (RARγ) selective agonist, for the treatment of two rare bone disorders, fibrodysplasia ossificans progressiva (FOP) and multiple osteochondromas (MO), and other diseases. The palovarotene regulatory submission for the prevention of heterotopic ossification (HO) in patients with FOP in the U.S.

Sartorius Starts off Fiscal 2019 with a Strong First Quarter18.4.2019 05:00:00 CESTPressemelding

Sartorius, a leading international partner of biopharmaceutical research and the industry, started off fiscal 2019 with substantial double-digit growth in order intake, sales revenue and earnings. Consolidated first-quarter sales revenue rose in constant currencies by 16.8% to 435.7 million (reported: +19.4%); order intake increased 16.6% to 482.8 million euros (reported: +19.3%). Sartorius’ underlying EBITDA1) surged 28.7% to 114.0 million euros. Its respective underlying EBITDA margin for the first three months of 2019 was 26.2% (Q1 2018: 24.3%), with a good half a percentage point of this increase resulting from the change in accounting rules2), as expected. Relevant net profit3) for the Group climbed 30.8% to 48.6 million euros. Earnings per ordinary share were 0.71 euros (Q1 2018: 0.54 euros); earnings per preference share, 0.72 euros (Q1 2018: 0.55 euros). “We are very pleased with our first-quarter results,” said Dr. Joachim Kreuzburg, CEO and Executive Board Chairman. “In Biopr